Overview
Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2022-08-31
2022-08-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aims to compare efficacy of Procedural Sedation with Dexmedetomidine as compared to Midazolam in the pediatric Emergency Department. 210 children aged 6 months to 6 years will be included and randomly assigned to receiving oral or rectal midazolam (standard of care) or intranasal dexmedetomidine for procedures at the emergency department where mainly a sedation and no analgesia is sought. The procedure will be videotaped and analysis is blinded to the medication.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University Hospital Inselspital, BerneTreatments:
Dexmedetomidine
Midazolam
Criteria
Inclusion Criteria:- Children aged between 6 months and 6 years presenting at the pediatric emergency
department
- Indication for midazolam as sedation
- Signed informed consent
Exclusion Criteria:
- Contraindication for midazolam
- Contraindication for dexmedetomidine
- Contraindication for moderate sedation in general